With fresh billions unlocked in the 2026 U.S. budget and mission‑driven family offices recalibrating after a “nuclear winter,” early stage biotechs are rewriting their financing strategies around ...

When planning environmental initiatives, antimicrobial resistance awareness programmes, or grant applications, AI helps map strategies and anticipate potential challenges. It offers perspectives that ...

Jason Kelly, chief executive of Ginkgo Bioworks, spent a surprising amount of time on an earnings call with analysts last ...

TrialAssure announced today announced the launch of its AI in Medical Writing Certification (AIMWC) Program, a new ...

Medimaps markets AI-driven bone microarchitecture imaging technologies such as TBS Osteo and TBS Reveal, which assess ...

The U.S. stock market kicked off 2026 with a volatile start, but by the end of February, the S&P 500 had clawed back its losses to close within just 1.8% of its all-time high. Looking ...

The Department of Health and Human Services (HHS) has told employees they can no longer use Claude, a generative artificial intelligence tool from Anthropic, as President Donald Trump seeks to ...

Investing Platform founder Adnan Tanveer reports strong deal flow at Emergence 2026, with opportunities spanning ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announced the pilot launch of its Automated AI-Driven Partnering System. This first ...

Fei-Fei Li is often called the grandmother of AI. As the new technology surges, she wants to make sure humanity is at its ...

Jazz Pharmaceuticals (NASDAQ:JAZZ) is one of the best cheap biotech stocks to buy now. Jazz Pharmaceuticals (NASDAQ:JAZZ) was ...